These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31281149)

  • 1. [Genetic abnormalities in AML].
    Nakajima H
    Rinsho Ketsueki; 2019; 60(6):584-593. PubMed ID: 31281149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
    Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
    Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of class I and II aberrations in Iraqi childhood acute myeloid leukemia using filter paper cards.
    Al-Kzayer LF; Uyen le TN; Al-Jadiry MF; Al-Hadad SA; Al-Badri SA; Ghali HH; Ameen NA; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Al-Ani MH; Saber PA; Khalil HM; Inoshita T; Kamata M; Koike K; Sakashita K
    Ann Hematol; 2014 Jun; 93(6):949-55. PubMed ID: 24464319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the most common chromosome translocations in adult acute myeloid leukemia.
    Mrózek K; Bloomfield CD
    J Natl Cancer Inst Monogr; 2008; (39):52-7. PubMed ID: 18648004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Mutation Profile in Acute Myeloid Leukemia Patients with
    Qin W; Chen X; Shen HJ; Wang Z; Cai X; Jiang N; Hua H
    Turk J Haematol; 2022 Jun; 39(2):84-93. PubMed ID: 35445594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of Genomic Landscape in Patients with Acute Myeloid Leukemia].
    Wang SM; Zheng HJ; Tian Y; Zhang JM; Yao JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):797-801. PubMed ID: 32552938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic abnormalities in core binding factor acute myeloid leukemia].
    Ishikawa Y
    Rinsho Ketsueki; 2017; 58(8):991-998. PubMed ID: 28883285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
    Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
    Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.
    Li Z; Lu J; Sun M; Mi S; Zhang H; Luo RT; Chen P; Wang Y; Yan M; Qian Z; Neilly MB; Jin J; Zhang Y; Bohlander SK; Zhang DE; Larson RA; Le Beau MM; Thirman MJ; Golub TR; Rowley JD; Chen J
    Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15535-40. PubMed ID: 18832181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematological & molecular profile of acute myelogenous leukaemia in India.
    Sazawal S; Kumar B; Hasan SK; Dutta P; Kumar R; Chaubey R; Mir R; Saxena R
    Indian J Med Res; 2009 Mar; 129(3):256-61. PubMed ID: 19491417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
    Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
    Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach.
    Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS
    Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.
    Metzeler KH; Bloomfield CD
    Adv Exp Med Biol; 2017; 962():175-199. PubMed ID: 28299658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.
    Eisfeld AK; Kohlschmidt J; Schwind S; Nicolet D; Blachly JS; Orwick S; Shah C; Bainazar M; Kroll KW; Walker CJ; Carroll AJ; Powell BL; Stone RM; Kolitz JE; Baer MR; de la Chapelle A; Mrózek K; Byrd JC; Bloomfield CD
    Leukemia; 2017 Jun; 31(6):1278-1285. PubMed ID: 27843138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics of newly diagnosed acute myeloid leukemia patients with NPM1 mutation].
    Wei H; Zhang YQ; Lin D; Wang Y; Zhou CL; Liu BC; Li W; Rao Q; Wang M; Mi YC; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):11-5. PubMed ID: 24598642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
    Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
    Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
    Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
    Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the miRNA sponge potential of RUNX1T1 in t(8;21) acute myeloid leukemia.
    Junge A; Zandi R; Havgaard JH; Gorodkin J; Cowland JB
    Gene; 2017 Jun; 615():35-40. PubMed ID: 28322996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.
    Bacher U; Haferlach T; Alpermann T; Zenger M; Hochhaus A; Beelen DW; Uppenkamp M; Rummel M; Kern W; Schnittger S; Haferlach C
    Br J Haematol; 2011 Mar; 152(6):713-20. PubMed ID: 21275954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach.
    Nomdedéu JF; Puigdecanet E; Bussaglia E; Hernández JJ; Carricondo M; Estivill C; Martí-Tutusaus JM; Tormo M; Zamora L; Serrano E; Perea G; de Llano MPQ; García A; Sánchez-Ortega I; Ribera JM; Nonell L; Aventin A; Solé F; Brunet MS; Sierra J
    Hematol Oncol; 2017 Dec; 35(4):778-788. PubMed ID: 27140599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.